![Aileron Therapeutics Inc](/common/images/company/N_ALRN.png)
Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in pat... Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. Show more
Aileron Therapeutics to be Included in the Russell Microcap® Index PR Newswire AUSTIN, Texas, July 1, 2024 AUSTIN, Texas, July 1, 2024 /PRNewswire/ -- Aileron Therapeutics, Inc. ("Aileron" or the...
Announced positive data from Cohort 1 of the Phase 1b clinical trial of LTI-03 in idiopathic pulmonary fibrosis (IPF) patients with positive trends observed in seven of the eight biomarkers...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.09 | -3.07167235495 | 2.93 | 3.13 | 2.6 | 35590 | 2.84931486 | CS |
4 | -0.16 | -5.33333333333 | 3 | 3.3 | 2.55 | 70558 | 2.96389448 | CS |
12 | -2.15 | -43.0861723447 | 4.99 | 5 | 2.55 | 88267 | 3.43947564 | CS |
26 | -1.49 | -34.4110854503 | 4.33 | 7.42 | 2.55 | 76812 | 4.26053538 | CS |
52 | 0.96 | 51.0638297872 | 1.88 | 7.42 | 1.01 | 74741 | 3.74056199 | CS |
156 | -19.16 | -87.0909090909 | 22 | 25.4 | 1.01 | 290437 | 9.24222963 | CS |
260 | -8.366 | -74.6564340532 | 11.206 | 49.4 | 1.01 | 621360 | 22.8140027 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.